WuXi Biologics is trading at HK$44.34, down 10.24%, in the supplied price context for October 22, 2026, amid a broad Hong Kong selloff.
- Reuters reported the Hang Seng fell 2.9% and the Hang Seng Tech Index dropped 4.6%, amid weaker sentiment and fading expectations for further Chinese stimulus.
- Recent coverage reported an FDA inspection passed and a sustainability award.
- The broader market is the likeliest context, not a confirmed stock-specific cause.